Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919445 | 0.95 | MEN1 (0.34) | MEN1CYP2C19KMT2A | |
| SCHEMBL23919273 | 0.91 | MEN1 (0.32) | MEN1CYP2C19KMT2A | |
| SCHEMBL23919409 | 0.89 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1CYP3A4HPGD | |
| SCHEMBL21870116 | 0.88 | ALDH1A1 (0.32) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL23919499 | 0.88 | ALDH1A1 (0.32) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL23919307 | 0.88 | HPGD (0.35) | MEN1CYP2C19KMT2AALDH1A1CYP3A4 | |
| SCHEMBL16216709 | 0.87 | MEN1 (0.39) | MEN1CYP2C19KMT2A | |
| SCHEMBL23919278 | 0.85 | ALDH1A1 (0.31) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL23919408 | 0.84 | ALDH1A1 (0.36) | MEN1CYP2C19KMT2AALDH1A1CYP3A4 | |
| SCHEMBL23919442 | 0.84 | ALDH1A1 (0.31) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | MEN1 2129/4885CYP2C19 1618/4885KMT2A 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.